The verdict
Phentermine suits a narrow situation: an adult who needs a short burst of appetite control, has no heart disease or high blood pressure, and accepts that it is meant for weeks rather than years. GLP-1 medicines suit men who want a treatment studied for long-term weight management, especially those with prediabetes, diabetes, high blood pressure or heart risk, where a stimulant is a poor match.
For most men over 35 weighing a medical program today, a GLP-1 medicine is the more common starting point, and phentermine is a conversation for specific cases.
Side-by-side comparison
| Phentermine | GLP-1 medicines (semaglutide, tirzepatide) | |
|---|---|---|
| Drug type | Stimulant appetite suppressant, Schedule IV controlled substance | Gut hormone mimics; tirzepatide also acts on GIP |
| Approved duration | Short term, a few weeks | Long-term weight management |
| How it is taken | Daily tablet or capsule | Weekly injection (semaglutide also has a daily tablet) |
| Typical weight loss | Modest; in one 28-week trial under half reached 5% loss | About 15% to 21% average in major trials |
| Heart rate and blood pressure | Can raise both | Not a stimulant; blood pressure often improves with weight loss |
| Main side effects | Dry mouth, constipation, palpitations, restlessness, insomnia | Nausea, constipation, diarrhea, less often gallbladder or pancreas problems |
| Cost pattern | Older generic, usually inexpensive | Brand medicines, usually the larger monthly expense |
How each one works
Phentermine belongs to the same chemical family as amphetamine. It stimulates the nervous system to blunt appetite, which is why its effects on heart rate, blood pressure and sleep come with it. The phentermine label describes it as a “short-term (a few weeks) adjunct” to a weight-reduction plan and classifies it as a Schedule IV controlled substance. It also warns that tolerance to the appetite effect develops, and that the dose should not be raised when that happens.
GLP-1 medicines work through a different route. They imitate hormones released by the gut after a meal, which signal fullness to the brain and slow stomach emptying. They are not stimulants, and they were tested in trials lasting more than a year.
What the trials show
The phentermine label itself states that the extra weight lost on drugs of this class compared with placebo is “only a fraction of a pound a week.” In a 28-week randomized trial, 43.3% to 46.2% of adults taking phentermine alone reached at least 5% weight loss, compared with 15.5% on placebo. The extended-release phentermine-topiramate combination did better, with average losses of 8.5% to 9.2% against 1.7% on placebo.
GLP-1 trials ran longer and showed larger averages. In STEP 1, semaglutide 2.4 mg produced a 14.9% average loss over 68 weeks versus 2.4% on placebo. In SURMOUNT-1, tirzepatide produced 15.0% to 20.9% over 72 weeks depending on dose, versus 3.1% on placebo. Trials differ in length and design, so the numbers are a guide rather than a head-to-head result.
Side effects and who should avoid each
MedlinePlus lists increased blood pressure and heart palpitations among the serious phentermine effects to report right away, and notes that it can be habit-forming. The label lists heart disease, hyperthyroidism, glaucoma, agitated states and pregnancy as reasons not to use it, and it should not be taken within two weeks of an MAO inhibitor. Rare but serious effects include pulmonary hypertension and heart valve disease.
GLP-1 medicines carry a different profile. Digestive side effects are common as the dose rises, and our page on semaglutide side effects covers how they are usually managed. Gallbladder disease and pancreatitis are less common but serious. These medicines are not used in men with a personal or family history of medullary thyroid cancer or MEN 2; the full list is on our page about who should not take semaglutide.
Chest pain, fainting or a racing heartbeat that will not settle on either medicine is an emergency: call 911 or go to the nearest ER.
Age and medical history shift the balance further. Men over 35 are more likely to have borderline blood pressure, early heart disease or sleep apnea that has not been diagnosed yet, and each of those makes a stimulant harder to justify. Many also take medicines for mood, migraines or blood pressure that need a careful interaction check before any appetite suppressant is added. A GLP-1 medicine is not free of interactions either: because it slows stomach emptying, the timing of some oral medicines may need review.
Cost and convenience
Phentermine wins on price and simplicity. It is an older generic taken once a day, so the medication cost is usually low. The catch is the short approved window, the blood pressure and pulse checks a stimulant needs, and the weight that often returns once the course ends.
GLP-1 medicines cost more each month and involve a weekly injection, but the dose schedule is built for long-term use and the visits that come with it check weight, body composition and labs together. Our tirzepatide weight loss program page explains how that schedule usually runs. If you are comparing every option, including surgery, see GLP-1 medication vs bariatric surgery.
How Ultimate Male approaches it
Ultimate Male’s medical weight loss program is built around semaglutide and tirzepatide, and phentermine is not part of the clinic’s menu. If you have taken phentermine before, or a previous clinician suggested it, your provider will talk through why and what it did for you, then explain what a GLP-1 plan would look like instead.
Every plan starts the same way: a free 10-minute call, on-site labs and a body composition analysis at San Gabriel or Downey, and a one-on-one consultation with a PA-C or MD. Blood pressure, heart history and current medicines are reviewed before anything is recommended.
